UPPER AERODIGESTIVE
TRACT: Report
MACROSCOPIC (check
all that apply)
SPECIMEN TYPE:
______________________________
TUMOR SITE
___ Lip
___ Oral cavity
___ Pharynx
___ Oropharynx
___ Hypopharynx
___ Nasopharynx
___ Larynx
___
Supraglottis
___
Glottis
___
Subglottis
___
Maxillary sinus
___
Ethmoid sinus
___ Salivary gland (specify:
____________________)
___ Unknown
TUMOR SIZE: _____ x _____ x _____
MICROSCOPIC (check
all that apply)
HISTOLOGIC TYPE
___ Squamous cell carcinoma
___ Verrucous squamous cell
carcinoma
___ Spindle cell carcinoma
___ Adenoid squamous cell carcinoma
___ Basaloid squamous cell carcinoma
___ Adenocarcinoma
___ Acinic cell carcinoma
___ Mucoepidermoid carcinoma
___ Adenoid cystic carcinoma
___ Carcinoma in pleomorphic adenoma
___ Epithelial-myoepithelial
carcinoma
___ Clear cell carcinoma
___ Adenosquamous carcinoma
___ Giant cell carcinoma
___ Salivary duct carcinoma
___ Carcinoid tumor
___ Atypical carcinoid tumor
___ Small cell carcinoma
___ Lymphoepithelial carcinoma
___ Undifferentiated carcinoma
___ Other (specify:
____________________________)
HISTOLOGIC GRADE
___ GX: Cannot be assessed
___ G1: Well differentiated
___ G2: Moderately differentiated
___ G3: Poorly differentiated
___ G4: Undifferentiated
EXTENT OF INVASION (see appropriate
site below)
Lip and Oral Cavity
___ TX: Cannot be assessed
___ T0: No evidence of primary tumor
___ Tis: Carcinoma in situ
___ T1: Tumor < 2 cm in greatest
dimension
___ T2: Tumor > 2 cm but < 4
cm in greatest dimension
___ T3: Tumor > 4 cm in greatest
dimension
___ T4: Lip: Tumor invades adjacent structures
(cortical bone, inferior alveolar nerve, floor of mouth, skin of face
Oral Cavity: Tumor invades adjacent structures (cortical bone, deep (extrinsic)
muscle of tongue, maxillary sinus, skin)
Pharynx
___ TX: Cannot be assessed
___ T0: No evidence of primary tumor
___ Tis: Carcinoma in situ
Oropharynx
___ T1: Tumor < 2 cm in
greatest dimension
___ T2: Tumor > 2 cm but < 4
cm in greatest dimension
___ T3: Tumor > 4 cm in greatest
dimension
___ T4: Tumor invades adjacent structures (pterygoid
muscles, mandible, hard palate, deep muscle of tongue, larynx)
Hypopharynx
___ T1: Tumor limited to one subsite
of hypopharynx and < 2 cm in greatest dimension
___ T2: Tumor invades more than one subsite of
hypopharynx or an adjacent site, or measures > 2 cm but < 4
cm in greatest dimension, without fixation of hemilarynx
___ T3: Tumor measures > 4 cm in
greatest dimension, or with fixation of hemilarynx
___ T4: Tumor invades adjacent structures
(thyroid/cricoid cartilage, carotid artery, soft tissues of neck, prevertebral fascia/muscles,
thyroid and/or esophagus)
Nasopharynx
___ T1: Tumor confined to
nasopharynx
___ T2: Tumor extends to soft tissue
of oropharynx and/or nasal fossa
___ T2a: without parapharyngeal
extension
___ T2b: with parapharyngeal
extension
___ T3: Tumor invades bony
structures and/or paranasal sinuses
___ T4: Tumor with intracranial extension and/or
involvement of cranial nerves, infratemporal fossa, hypopharynx or orbit
Supraglottis
___ TX: Cannot be assessed
___ T0: No evidence of primary tumor
___ Tis: Carcinoma in situ
___ T1: Tumor limited to one subsite
of supraglottis with normal vocal cord mobility
___ T2: Tumor invades muscosa of more than one
adjacent subsite of supraglottis or glottis or region outside the supraglottis,
(muscosa of base of tongue, vallecula, medial wall of piriform sinus) without
fixation of the larynx
___ T3: Tumor limited to larynx with vocal cord
fixation and/or invades any of the following: postcricoid area, pre-epiglottic
tissues, deep base of tongue
___ T4: Tumor invades through thyroid cartilage,
and/or extends into soft tissues of the neck, thyroid, and/or esophagus
Glottis
___ TX: Cannot be assessed
___ T0: No evidence of primary tumor
___ Tis: Carcinoma in situ
___ T1: Tumor limited to vocal cord(s) (may involve
anterior or posterior commissure) with normal mobility
___ T1a: Tumor limited to one vocal
cord
___ T1b: Tumor involves both vocal
cords
___ T2: Tumor extends to
supraglottis and/or subglottis, and/or with impaired vocal cord mobility
___ T3: Tumor limited to larynx with
vocal cord fixation
___ T4: Tumor invades through thyroid cartilage
and/or extends to other tissues beyond the larynx (trachea, soft tissues of
neck, thyroid, pharynx)
Subglottis
___ TX: Cannot be assessed
___ T0: No evidence of primary tumor
___ Tis: Carcinoma in situ
___ T1: Tumor limited to subglottis
___ T2: Tumor extends to vocal
cord(s) with normal or impaired mobility
___ T3: Tumor limited to larynx with
vocal cord fixation
___ T4: Tumor invades through cricoid or thyroid
cartilage and/or extends into other tissues beyond the larynx (trachea, soft
tissues of neck, thyroid, esophagus)
Maxillary Sinus
___ TX: Cannot be assessed
___ T0: No evidence of primary tumor
___ Tis: Carcinoma in situ
___ T1: Tumor limited to the antral
mucosa with no erosion or destruction of bone
___ T2: Tumor causing bone erosion or destruction,
except for the posterior antral wall, including extension into hard palate
and/or middle nasal meatus
___ T3: Tumor invades any of the following: bone of
posterior wall of maxillary sinus, subcutaneous tissues, skin of cheek, floor
or medial wall of orbit, infratemporal fossa, pterygoid plates, ethmoid sinuses
___ T4: Tumor invades orbital contents beyond the
floor or medial wall including apex and/or any of the following: cribriform
plate, base of skull, nasopharynx, sphenoid sinus, frontal sinus
Ethmoid Sinus
___ TX: Cannot be assessed
___ T0: No evidence of primary tumor
___ Tis: Carcinoma in situ
___ T1: Tumor confined to ethmoid
with or without bone erosion
___ T2: Tumor extends into nasal
cavity
___ T3: Tumor extends to anterior
orbit and/or maxillary sinus
___ T4: Tumor with intracranial extension, orbital
extension including apex, involving sphenoid and/or frontal sinus and/or skin
of nose
Salivary Glands
___ TX: Cannot be assessed
___ T0: No evidence of primary tumor
___ T1: Tumor < 2 cm in
greatest dimension without extraparenchymal extension
___ T2: Tumor > 2 cm but <
4 cm in greatest dimension without extraparenchymal extension
___ T3: Tumor having extraparenchymal extension
without seventh nerve involvement, and/or > 4 cm but < 6 cm
in greatest dimension
___ T4: Tumor invades base of skull, seventh nerve,
and/or exceeds 6 cm in greatest dimension
MARGINS
___ Margins uninvolved by tumor
Distance
of tumor from closest margin: ___ cm
(Specify
margin: __________________________
_________________________________________)
___ Margin(s) involved by tumor
Specify
location(s): _______________________
BLOOD/LYMPHATIC VESSEL INVASION
___ Absent
___ Present
___ Indeterminate
REGIONAL LYMPH NODES (see
appropriate site)
All Sites Except Nasopharynx
___ NX: Cannot be assessed
___ N0: No regional lymph node
metastasis
___ N1: Metastasis in a single
ipsilateral lymph node, < 3 cm in greatest dimension
___ N2: Metastasis in a single ipsilateral lymph node
> 3 cm but < 6 cm in greatest dimension; or in multiple
ipsilateral lymph nodes, none > 6 cm in greatest dimension; or in bilateral
or contralateral lymph nodes, none > 6 cm in greatest dimension
___ N2a: Metastasis in a single
ipsilateral lymph node, > 3 cm but < 6 cm in greatest dimension
___ N2b: Metastasis in multiple
ipsilateral lymph nodes, none > 6 cm in greatest dimension
___ N2c: Metastasis in bilateral or
contralateral lymph nodes, none > 6 cm in greatest dimension
___ N3: Metastasis in a lymph node
> 6 cm in greatest dimension
Nasopharynx
___ NX: Cannot be assessed
___ N0: No regional lymph node
metastasis
___ N1: Unilateral metastasis in lymph node(s) >
6 cm in greatest dimension, above supraclavicular fossa
___ N2: Bilateral metastasis in lymph node(s) >
6 cm in greatest dimension, above supraclavicular fossa
___ N3: Metastasis in lymph node(s)
___
N3a: > 6 cm in dimension
___
N3b: extension to supraclavicular fossa
DISTANT METASTASIS
___ MX: Cannot be assessed
___ M0: No distant metastasis
___ M1: Distant metastasis
(site(s):______________
__________________________________________)
ADDITIONAL PATHOLOGIC FINDINGS
___ None identified
___ Inflammation (specify type:
_________________)
___ Epithelial hyperplasia
___ Epithelial dysplasia
___ Other (specify:
____________________________)
COMMENT
___________________________________________
___________________________________________
___________________________________________
___________________________________________